Page last updated: 2024-10-21

3-methoxytyramine and Cerebral Ischemia

3-methoxytyramine has been researched along with Cerebral Ischemia in 1 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Research Excerpts

ExcerptRelevanceReference
"During 30 minutes of global forebrain ischemia in rats, striatal intracellular levels of dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) increase at the same time extracellular levels, measured by microdialysis, decrease."3.69Ischemia increases tissue and decreases extracellular levels of acid dopamine metabolites in the rat striatum: further evidence for active transport of metabolites. ( Clemens, JA; Mincy, RE; Phebus, LA, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Phebus, LA1
Mincy, RE1
Clemens, JA1

Other Studies

1 other study available for 3-methoxytyramine and Cerebral Ischemia

ArticleYear
Ischemia increases tissue and decreases extracellular levels of acid dopamine metabolites in the rat striatum: further evidence for active transport of metabolites.
    Life sciences, 1995, Feb-17, Volume: 56, Issue:13

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biological Transport, Active; Brain Ischemia; Corpus Striat

1995